Skip to main content
logo
Union Korea Pharm Co., Ltd. (KOSDAQ:080720)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,725.00
-310.00 (-10.21%)
At close: Oct 11, 2024

Union Korea Pharm Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
29,66136,37851,28063,16961,29348,304
Revenue Growth
-37.38%-29.06%-18.82%3.06%26.89%-4.12%
Gross Profit
4,7617,75914,12420,78123,91715,150
Operating Income
-23,114-23,326-18,654-14,6821,271-10,615
Net Income
-30,544-30,820-20,916-18,156-932.02-11,109
Earnings Per Share
-4225.64-4263.09-2894.00-2514.45-126.31-1430.00
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
7,0976,5815,7617,1817,52421,120
Total Debt
23,37321,43323,99339,34937,12535,867
Net Cash (Debt)
-16,275-14,853-18,232-32,169-29,601-14,747
Net Cash Growth
------
Net Cash Per Share
-2251.59-2054.46-2522.59-4455.02-4011.66-1897.72

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-3,412-1,134420.211,362-5,0631,915
Capital Expenditures
-130.74-95.74-949.44-2,263-3,366-7,168
Free Cash Flow
-3,543-1,230-529.23-901.15-8,429-5,254
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
16.05%21.33%27.54%32.90%39.02%31.36%
Operating Margin
-77.92%-64.12%-36.38%-23.24%2.07%-21.98%
Pretax Margin
-92.82%-76.44%-37.00%-22.80%1.54%-29.97%
Profit Margin
-102.98%-84.72%-40.79%-28.74%-1.52%-23.00%
FCF Margin
-11.95%-3.38%-1.03%-1.43%-13.75%-10.88%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
0.660.540.300.570.841.62